Clinical Trials Browser

Phase 1/2 × OTHER × Daclizumab × Clear all

Hodgkin Disease, Leukemia, Lymphoma, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

NCT00847106 2009-02-19

Augmentation of Dendritic Cell-Based Vaccines in Melanoma Patients by Depletion of Regulatory T Cells in Stage IV Melanoma Patients

Phase 1/2 Completed

15 enrolled

Dermatologic

Melanoma

Clinical Trials

Monoclonal Antibody Plus Interleukin-2 in Treating Patients With Leukemia or Lymphoma

Augmentation of Dendritic Cell-Based Vaccines in Melanoma Patients by Depletion of Regulatory T Cells in Stage IV Melanoma Patients